Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTXCHOY, Ernest; MCKENNA, Frank; VENCOVSKY, Jiri et al.Rheumatology (Oxford. Print). 2012, Vol 51, Num 7, pp 1226-1234, issn 1462-0324, 9 p.Article

Hypothalamus-Pituitary-Adrenal Axis Function in Patients with Rheumatoid Arthritis Treated with Nighttime-Release PrednisoneALTEN, Rieke; DÖRING, Gisela; CUTOLO, Maurizio et al.Journal of rheumatology. 2010, Vol 37, Num 10, pp 2025-2031, issn 0315-162X, 7 p.Article

HLA-DRB1 genes, rheumatoid factor, and elevated C-reactive protein : Independent risk factors of radiographic progression in early rheumatoid arthritisLISTING, Joachim; RAU, Rolf; MÜLLER, Brigitte et al.Journal of rheumatology. 2000, Vol 27, Num 9, pp 2100-2109, issn 0315-162XArticle

Identifying Preliminary Domains to Detect and Measure Rheumatoid Arthritis Flares: Report of the OMERACT 10 RA Flare WorkshopBINGHAM, Clifton O; ALTEN, Rieke; MAY, James E et al.Journal of rheumatology. 2011, Vol 38, Num 8, pp 1751-1758, issn 0315-162X, 8 p.Article

Physical Inactivity in Patients With Rheumatoid Arthritis : Data From Twenty-One Countries in a Cross-Sectional, International StudySOKKA, Tuulikki; HÄKKINEN, Arja; ALTEN, Rieke et al.Arthritis care and research. 2008, Vol 59, Num 1, pp 42-50, issn 0893-7524, 9 p.Article

Costimulatory blockade in patients with rheumatoid arthritis: A pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusionMORELAND, Larry W; ALTEN, Rieke; BECKER, Jean-Claude et al.Arthritis and rheumatism. 2002, Vol 46, Num 6, pp 1470-1479, issn 0004-3591Article

Patient's global assessment of disease activity and patient's assessment of general health for rheumatoid arthritis activity assessment: are they equivalent?AHMED KHAN, Nasim; SPENCER, Horace Jack; LUND HETLAND, Merete et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 12, pp 1942-1949, issn 0003-4967, 8 p.Article

Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1) : a double-blind, randomised controlled trial. CommentaryBIJLSMA, Johannes W. J; JACOBS, Johannes W. G; SZECHINSKI, Jacek et al.Lancet (British edition). 2008, Vol 371, Num 9608, issn 0140-6736, 183-184, 205-214 [12 p.]Article

Establishing a Core Domain Set to Measure Rheumatoid Arthritis Flares: Report of the OMERACT 11 RA Flare WorkshopBYKERK, Vivian P; LIE, Elisabeth; MARCH, Lyn et al.Journal of rheumatology. 2014, Vol 41, Num 4, pp 799-809, issn 0315-162X, 11 p.Article

Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years—early clinical response predicts long-term outcomeBARALIAKOS, Xenofon; LISTING, Joachim; SCHMIDT, Reinhold et al.Rheumatology (Oxford. Print). 2011, Vol 50, Num 9, pp 1690-1699, issn 1462-0324, 10 p.Article

Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritisBUTTGEREIT, Frank; DOERING, Gisela; SCHAEFFLER, Achim et al.Annals of the rheumatic diseases. 2010, Vol 69, Num 7, pp 1275-1280, issn 0003-4967, 6 p.Article

Standardizing assessment and reporting of adverse effects in rheumatology clinical trials. II: The rheumatology common toxicity criteria v.2.0WOODWORTH, Thasia; FURST, Daniel E; JOHNSON, Kent et al.Journal of rheumatology. 2007, Vol 34, Num 6, pp 1401-1414, issn 0315-162X, 14 p.Conference Paper

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trialGABAY, Cem; EMERY, Paul; KAVANAUGH, Arthur et al.Lancet (British edition). 2013, Vol 381, Num 9877, pp 1541-1550, issn 0140-6736, 10 p.Article

'I'm hurting, I want to kill myself': rheumatoid arthritis flare is more than a high joint count-an international patient perspective on flare where medical help is soughtHEWLETT, Sarah; SANDERSON, Tessa; MAY, James et al.Rheumatology (Oxford. Print). 2012, Vol 51, Num 1, pp 69-76, issn 1462-0324, 8 p.Article

Determinants of Discordance in Patients' and Physicians' Rating of Rheumatoid Arthritis Disease ActivityKHAN, Nasim A; SPENCER, Horace J; GEORGESCU, Lia et al.Arthritis care and research. 2012, Vol 64, Num 2, pp 206-214, issn 0893-7524, 9 p.Article

Developing a Construct to Evaluate Flares in Rheumatoid Arthritis: A Conceptual Report of the OMERACT RA Flare Definition Working GroupALTEN, Rieke; POHL, Christof; WOODWORTH, Thasia G et al.Journal of rheumatology. 2011, Vol 38, Num 8, pp 1745-1750, issn 0315-162X, 6 p.Article

Safety and efficacy of readministration of infliximab after longterm continuous therapy and withdrawal in patients with ankylosing spondylitisBARALIAKOS, Xenofon; LISTING, Joachim; SORENSEN, Helmut et al.Journal of rheumatology. 2007, Vol 34, Num 3, pp 510-515, issn 0315-162X, 6 p.Article

OMERACT Endorsement of Measures of Outcome for Studies of Acute GoutSINGH, Jasvinder A; TAYLOR, William J; KHANNA, Dinesh et al.Journal of rheumatology. 2014, Vol 41, Num 3, pp 569-573, issn 0315-162X, 5 p.Article

Subcutaneous Abatacept for the Treatment of Rheumatoid Arthritis: Longterm Data from the ACQUIRE TrialGENOVESE, Mark C; TENA, César Pacheco; LEGERTON, Clarence William et al.Journal of rheumatology. 2014, Vol 41, Num 4, pp 629-639, issn 0315-162X, 11 p.Article

Identifying core domains to assess flare in rheumatoid arthritis: an OMERACT international patient and provider combined Delphi consensusBARTLETT, Susan J; HEWLETT, Sarah; LEONG, Amye L et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 11, pp 1855-1860, issn 0003-4967, 6 p.Article

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study) : a double-blind, placebo-controlled, randomised trial. CommentaryBONGARTZ, Tim; SMOLEN, Josef S; BEAULIEU, Andre et al.Lancet (British edition). 2008, Vol 371, Num 9617, issn 0140-6736, 961-963, 987-997 [14 p.]Article

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4IgKREMER, Joel M; WESTHOVENS, Rene; WILLIAMS, G. Rhys et al.The New England journal of medicine. 2003, Vol 349, Num 20, pp 1907-1915, issn 0028-4793, 9 p.Article

Developing a Standardized Definition for Disease Flare in Rheumatoid Arthritis (OMERACT 9 Special Interest Group)BINGHAM, Clifton O; POHL, Christoph; ALTEN, Rieke E et al.Journal of rheumatology. 2009, Vol 36, Num 10, pp 2335-2341, issn 0315-162X, 7 p.Conference Paper

Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensionsSCHLESINGER, Naomi; ALTEN, Rieke E; BARDIN, Thomas et al.Annals of the rheumatic diseases. 2012, Vol 71, Num 11, pp 1839-1848, issn 0003-4967, 10 p.Article

Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)BUTTGEREIT, Frank; MEHTA, Daksha; SAAG, Kenneth G et al.Annals of the rheumatic diseases. 2013, Vol 72, Num 2, pp 204-210, issn 0003-4967, 7 p.Article